AZENTA INC (AZTA) Fundamental Analysis & Valuation
NASDAQ:AZTA • US1143401024
Current stock price
23.33 USD
+1.12 (+5.04%)
At close:
23.33 USD
0 (0%)
After Hours:
This AZTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AZTA Profitability Analysis
1.1 Basic Checks
- In the past year AZTA was profitable.
- AZTA had a positive operating cash flow in the past year.
- In multiple years AZTA reported negative net income over the last 5 years.
- AZTA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- AZTA has a Return On Assets (-2.79%) which is in line with its industry peers.
- AZTA has a better Return On Equity (-3.37%) than 61.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROIC | N/A |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Gross Margin of AZTA (44.59%) is comparable to the rest of the industry.
- AZTA's Gross Margin has been stable in the last couple of years.
- AZTA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
2. AZTA Health Analysis
2.1 Basic Checks
- AZTA does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for AZTA has been increased compared to 1 year ago.
- AZTA has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, AZTA has an improved debt to assets ratio.
2.2 Solvency
- AZTA has an Altman-Z score of 3.21. This indicates that AZTA is financially healthy and has little risk of bankruptcy at the moment.
- With a decent Altman-Z score value of 3.21, AZTA is doing good in the industry, outperforming 70.18% of the companies in the same industry.
- There is no outstanding debt for AZTA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 3.21 |
ROIC/WACCN/A
WACC10.8%
2.3 Liquidity
- A Current Ratio of 2.92 indicates that AZTA has no problem at all paying its short term obligations.
- AZTA's Current ratio of 2.92 is in line compared to the rest of the industry. AZTA outperforms 54.39% of its industry peers.
- AZTA has a Quick Ratio of 2.61. This indicates that AZTA is financially healthy and has no problem in meeting its short term obligations.
- With a Quick ratio value of 2.61, AZTA perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 |
3. AZTA Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an nice 14.89% over the past year.
- Measured over the past years, AZTA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.04% on average per year.
- Looking at the last year, AZTA shows a decrease in Revenue. The Revenue has decreased by -8.40% in the last year.
- The Revenue has been growing by 8.86% on average over the past years. This is quite good.
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
3.2 Future
- Based on estimates for the next years, AZTA will show a very strong growth in Earnings Per Share. The EPS will grow by 27.49% on average per year.
- AZTA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.37% yearly.
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue Next Year5.15%
Revenue Next 2Y5.46%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. AZTA Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 43.20, the valuation of AZTA can be described as expensive.
- Based on the Price/Earnings ratio, AZTA is valued a bit cheaper than the industry average as 61.40% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of AZTA to the average of the S&P500 Index (27.18), we can say AZTA is valued expensively.
- Based on the Price/Forward Earnings ratio of 21.37, the valuation of AZTA can be described as rather expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of AZTA indicates a somewhat cheap valuation: AZTA is cheaper than 78.95% of the companies listed in the same industry.
- AZTA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 37.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.2 | ||
| Fwd PE | 21.37 |
4.2 Price Multiples
- 84.21% of the companies in the same industry are more expensive than AZTA, based on the Enterprise Value to EBITDA ratio.
- AZTA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AZTA is cheaper than 63.16% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.74 | ||
| EV/EBITDA | 13.54 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as AZTA's earnings are expected to grow with 35.52% in the coming years.
PEG (NY)0.86
PEG (5Y)N/A
EPS Next 2Y43.51%
EPS Next 3Y35.52%
5. AZTA Dividend Analysis
5.1 Amount
- AZTA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AZTA Fundamentals: All Metrics, Ratios and Statistics
23.33
+1.12 (+5.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)05-05 2026-05-05/amc
Inst Owners116.07%
Inst Owner Change0.01%
Ins Owners0.69%
Ins Owner Change12.39%
Market Cap1.07B
Revenue(TTM)594.95M
Net Income(TTM)-57.85M
Analysts77.14
Price Target37.74 (61.77%)
Short Float %10.54%
Short Ratio5.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.65%
Min EPS beat(2)-35.95%
Max EPS beat(2)8.65%
EPS beat(4)2
Avg EPS beat(4)-5.26%
Min EPS beat(4)-35.95%
Max EPS beat(4)36.22%
EPS beat(8)6
Avg EPS beat(8)46.66%
EPS beat(12)9
Avg EPS beat(12)140.12%
EPS beat(16)13
Avg EPS beat(16)118.13%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)-0.05%
Revenue beat(4)0
Avg Revenue beat(4)-1.7%
Min Revenue beat(4)-5.56%
Max Revenue beat(4)-0.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.26%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)-1.08%
PT rev (1m)-1.89%
PT rev (3m)-4.78%
EPS NQ rev (1m)-0.49%
EPS NQ rev (3m)-24.05%
EPS NY rev (1m)-0.71%
EPS NY rev (3m)-0.16%
Revenue NQ rev (1m)0.22%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0.47%
Revenue NY rev (3m)0.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 43.2 | ||
| Fwd PE | 21.37 | ||
| P/S | 1.81 | ||
| P/FCF | 34.74 | ||
| P/OCF | 17.22 | ||
| P/B | 0.63 | ||
| P/tB | 1.17 | ||
| EV/EBITDA | 13.54 |
EPS(TTM)0.54
EY2.31%
EPS(NY)1.09
Fwd EY4.68%
FCF(TTM)0.67
FCFY2.88%
OCF(TTM)1.35
OCFY5.81%
SpS12.92
BVpS37.23
TBVpS19.88
PEG (NY)0.86
PEG (5Y)N/A
Graham Number21.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.79% | ||
| ROE | -3.37% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.59% | ||
| FCFM | 5.2% |
ROA(3y)-3.69%
ROA(5y)10.48%
ROE(3y)-4.38%
ROE(5y)11.73%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.36%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 55.45% | ||
| Cap/Sales | 5.29% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 156.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.92 | ||
| Quick Ratio | 2.61 | ||
| Altman-Z | 3.21 |
F-Score5
WACC10.8%
ROIC/WACCN/A
Cap/Depr(3y)47.53%
Cap/Depr(5y)73.52%
Cap/Sales(3y)6.46%
Cap/Sales(5y)8.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y0.64%
EPS 5Y-16.04%
EPS Q2Q%12.5%
EPS Next Y50.47%
EPS Next 2Y43.51%
EPS Next 3Y35.52%
EPS Next 5Y27.49%
Revenue 1Y (TTM)-8.4%
Revenue growth 3Y2.25%
Revenue growth 5Y8.86%
Sales Q2Q%0.77%
Revenue Next Year5.15%
Revenue Next 2Y5.46%
Revenue Next 3Y5.78%
Revenue Next 5Y5.37%
EBIT growth 1Y71.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year493.88%
EBIT Next 3Y107.95%
EBIT Next 5YN/A
FCF growth 1Y-4.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.01%
OCF growth 3YN/A
OCF growth 5Y13.75%
AZENTA INC / AZTA Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for AZENTA INC?
ChartMill assigns a fundamental rating of 5 / 10 to AZTA.
What is the valuation status for AZTA stock?
ChartMill assigns a valuation rating of 5 / 10 to AZENTA INC (AZTA). This can be considered as Fairly Valued.
Can you provide the profitability details for AZENTA INC?
AZENTA INC (AZTA) has a profitability rating of 3 / 10.
How financially healthy is AZENTA INC?
The financial health rating of AZENTA INC (AZTA) is 8 / 10.
What is the expected EPS growth for AZENTA INC (AZTA) stock?
The Earnings per Share (EPS) of AZENTA INC (AZTA) is expected to grow by 50.47% in the next year.